ConforMIS Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CFMS Nasdaq 3841 http://www.conformis.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ConforMIS Inc

Conformis, Inc. (NASDAQ:CFMS) Q1 2023 Earnings Call Transcript - May 10th, 2023 10:10 pm
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates - May 8th, 2023 1:15 pm
Conformis Reports First Quarter 2023 Financial Results - May 8th, 2023 12:05 pm
Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023 - Apr 13th, 2023 8:30 pm
Neogen (NEOG) Q3 Earnings Beat Estimates, Revenues Rise Y/Y - Mar 31st, 2023 2:36 pm
Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures - Mar 21st, 2023 11:00 am
Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Dips - Mar 10th, 2023 1:26 pm
ConforMIS (CFMS) Moves to Buy: Rationale Behind the Upgrade - Mar 6th, 2023 5:00 pm
Conformis Full Year 2022 Earnings: Beats Expectations - Mar 4th, 2023 12:40 pm
Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results - Mar 1st, 2023 9:05 pm
Conformis, Inc. to Participate in Upcoming Investor Conferences - Feb 21st, 2023 9:15 pm
Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation - Feb 15th, 2023 9:15 pm
Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022 - Feb 10th, 2023 12:00 pm
Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022 - Jan 23rd, 2023 9:30 pm
Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule - Nov 30th, 2022 9:30 pm
Conformis Announces First Procedure Performed Using New Actera™ Hip System - Nov 29th, 2022 12:30 pm
Conformis Announces Full Commercial Launch of Imprint™ - Nov 17th, 2022 12:00 pm
Conformis, Inc. Announces Settlement of Medacta Patent Litigation - Nov 14th, 2022 9:15 pm
Conformis, Inc.'s (NASDAQ:CFMS) 48% loss last week hit both individual investors who own 52% as well as institutions - Nov 11th, 2022 1:41 pm
Conformis, Inc. Effects 1-for-25 Reverse Stock Split - Nov 9th, 2022 12:00 pm